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Abstract
Background: Diabetes mellitus is a serious and increasing health problem in Australia and is a designated
national health priority. Diabetes and related conditions represent an even greater health burden among
Indigenous Australians (Aborigines and Torres Strait Islanders), but there are critical gaps in knowledge
relating to the incidence and prevalence, aetiology, and prevention of diabetes in this group, including a
lack of information on the burden of disease among Indigenous people in urban areas. The DRUID Study
(Diabetes and Related conditions in Urban Indigenous people in the Darwin region) was designed to
address this knowledge gap.
Methods/design: The study was conducted in a specified geographic area in and around Darwin,
Australia. Eligible participants underwent a health examination, including collection of blood and urine
samples, clinical and anthropometric measurements, and administration of questionnaires, with an
additional assessment for people with diabetes. The study was designed to incorporate local Indigenous
leadership, facilitate community engagement, and provide employment and training opportunities for local
Indigenous people. A variety of recruitment methods were used. A total of 1,004 eligible people gave
consent and provided at least one measurement. When compared with census data for the Indigenous
population living in the study area, there was a marked under-representation of males, but no substantial
differences in age, place of residence, Indigenous group, or household income. Early participants were
more likely than later participants to have previously diagnosed diabetes.
Discussion: Despite lower than anticipated recruitment, this is, to our knowledge, the largest study ever
conducted on the health of Indigenous Australians living in urban areas, a group which comprises the
majority of Australia's Indigenous population but about whose health and wellbeing relatively little is
known. The study is well-placed to provide new information that can be used by policy makers and service
providers to improve the delivery of services and programs that affect the health of Indigenous people. It
also represents a valuable opportunity to establish an urban Indigenous cohort study, provided participants
can be followed successfully over time.
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Diabetes mellitus, predominantly type 2, is a serious and
increasing health problem in Australia and has been des-
ignated a national health priority area [1]. AusDiab, the
first Australian national diabetes and lifestyle study,
showed a diabetes prevalence of 7.4% in adults aged 25
years and over in 1999–2000, one of the highest for a
Western nation [2]. Diabetes and related conditions rep-
resent an even greater health burden among Indigenous
Australians (Aboriginal and Torres Strait Islander people).
A number of studies in Indigenous communities in rural
and remote areas have shown that the prevalence of dia-
betes is higher and the age of onset lower than among
Australians overall [3,4]. Because the risk of complica-
tions increases with the duration of diabetes, an earlier age
of onset means that Indigenous people with diabetes are
likely to have significantly worse health than non-Indige-
nous people with diabetes of the same age.
Indigenous adults aged 25–54 years were hospitalised for
diabetes at about 15–18 times the rate for non-Indigenous
adults in 2001–02; death rates from diabetes among those
aged 35–54 years were 27–35 times higher for Indigenous
than non-Indigenous people in 2000–02 [5].
According to an extensive review of diabetes in Aboriginal
and Torres Strait Islander populations [4], there remain
critical gaps in knowledge relating to the incidence and
prevalence, aetiology, and prevention of diabetes in this
group. Among the areas highlighted by the review were:
the lack of information on the burden of disease among
Indigenous people in urban areas; the inadequacy of data
on the prevalence and incidence of diabetes-related com-
plications; and the relative lack of evaluations of the effec-
tiveness of lifestyle interventions in preventing diabetes
and cardiovascular disease in Indigenous populations.
The DRUID Study (Diabetes and Related conditions in
Urban Indigenous people in the Darwin region) was
designed to provide important new information in each
of these areas, although the extent to which it was able to
do so was variable.
Methods/design
Aims & objectives
The main aims of the DRUID Study were to:
• provide the first accurate assessment of the burden of
diabetes, diabetic complications and associated chronic
diseases in an urban Indigenous population, and to make
comparisons with Australian-wide data;
• work with an urban Indigenous community to plan,
implement and evaluate interventions to reduce the inci-
dence of diabetes among those at high risk;
• facilitate contact with, and use of, appropriate services
for people with diabetes and related disorders;
• increase awareness and understanding of diabetes
among Indigenous people in the Darwin region;
• facilitate community engagement and provide educa-
tion, employment and training opportunities for Indige-
nous people in an urban area;
• increase the capacity of Indigenous people to prevent
diabetes; and
• increase the capacity of Indigenous people with diabetes
and related disorders to manage their health in partner-
ship with health service providers.
The study was intended to have three parts. The first part
was baseline data collection, which combined recruit-
ment and a health examination. This component, which
is the subject of this paper, was expected to take approxi-
mately one year, but took approximately 50% longer, pri-
marily due to slower than anticipated recruitment, as is
discussed in detail below. The second component, a
healthy lifestyle intervention among people with
impaired glucose tolerance (IGT) and impaired fasting
glucose (IFG), was expected to take place in years 2–5 of
the study. This component was subsequently cancelled
because the lower than expected number of total partici-
pants resulted in insufficient numbers of study partici-
pants with IFG or IGT. The third component – annual
follow-up of participants to collect information on their
vital status, incidence of selected major conditions and
use of health services – is soon to commence.
In addition to undertaking formal data collection activi-
ties, it was intended that the study would increase diabetes
awareness and provide opportunities for health education
and health promotion, both through the provision of
results and targeted health information to participating
individuals, and through partnerships among researchers,
service delivery organisations and advocacy bodies.
Setting and location
The study was conducted in and around Darwin, a city of
approximately 100,000 people located on the northern
coast of Australia. At the time of planning the study, Dar-
win had a number of characteristics that were expected to
greatly enhance the feasibility of the study and the identi-
fication, recruitment and follow up of participants, such
as: perceived community support for, and potential
involvement in, the study; strong and stable family net-
works; excellent identification of Indigenous people in
the relevant administrative collections; a relatively high
number of Indigenous people in a relatively small totalPage 2 of 23
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health practitioners through the Cooperative Research
Centre for Aboriginal Health and other forums; and a
pool of local Indigenous people who had research experi-
ence and/or could be trained to participate actively in the
conduct of the study. In addition, the Darwin Indigenous
population was similar to the total Australian Indigenous
population on a range of socio-demographic and health
risk factor variables, such as unemployment rate, post-
school qualifications, household size, proportion of
households in rented accommodation, smoking status,
and proportion overweight/obese [6,7]. This was expected
to greatly enhance the generalisability of the study.
Funding
Major funding was provided by the National Health and
Medical Research Council of Australia (project grant
#236207). Supplementary funding was provided by the
Vincent Fairfax Family Foundation, the Clive and Vera
Ramaciotti Foundation (equipment grant # RA040/03),
the Australian Government Department of Employment
and Workplace Relations, and the AusDiab Partnership in
type 2 diabetes. Several organisations provided in-kind
support, as described below.
Organisational structure
The Study was intended to be run as a partnership involv-
ing researchers, health service providers and Indigenous
people and organisations. A number of groups were
formed to support this partnership approach, including a
management group, an Indigenous Steering Group (ISG),
a technical reference group (TRG), and the project team.
In order to facilitate communication, there was cross-rep-
resentation across these groups.
The management group, comprising investigators and the
project manager, had ultimate financial and scientific
responsibility for the study overall. The ISG was intended
to represent Indigenous groups in the local area and pro-
vide leadership and ensure practical benefits to the Indig-
enous community. Members were primarily Indigenous
residents of the Darwin region who had a strong interest
in health issues and who saw diabetes as an important
issue for themselves, their families and their community.
The TRG was intended to provide technical expertise and
guidance and contribute to the rigor and efficiency of the
study. Most of the work of this group was done in smaller
groups on an ad hoc basis. Members included researchers
and service providers chosen on the basis of their expertise
and interest in the study. The project team was responsible
for the day to day management and implementation of
the study in keeping with broad directions set by the man-
agement group and the ISG.
A number of organisations were identified as project part-
ners. These organisations indicated their support for the
Table 1: Contributions of DRUID Study Partner Organisations
Organisation Contribution
Menzies School of Health Research Two investigators, several ISG members, several TRG members, 
employment of the project team, three post-graduate research students, 
development of study protocols, provision of testing and office facilities, 
hosting of group meetings, garage and storage facilities, freezer space, 
general study infrastructure
Northern Territory Department of Health and Community Services Two investigators, several ISG members, several TRG members, testing 
facilities at several locations, major mail-out to potential participants, 
input to study design, on-premises recruitment
Danila Dilba Health Service Several ISG members, TRG members, Eye Health Worker for 
complications assessment, hosting of majority of ISG meetings, provision 
of occasional testing facilities, some recruitment
International Diabetes Institute Two investigators, TRG members, provision of training for 
complications assessment, input to study design, advice on several 
aspects of the study including data management and laboratory setup, 
use of a proprietary software package, links with the AusDiab 
Partnership in Type 2 Diabetes and other national organisations
Cooperative Research Centre for Aboriginal Health Two investigators, ISG members, assistance with development of the 
communications strategy, assistance with education and training issues
Yilli Rreung ATSIC Regional Council ISG member (sitting fees were provided by the Council to enable 
attendance as part of official Council duties)
Diabetes Australia NT TRG members, diabetes awareness training as part of staff orientation, 
educational resources, health education for participants at some 
complications screenings
Top End Division of General Practice TRG members, facilitation of communication with general medical 
practitioners
National Heart Foundation (NT) TRG memberPage 3 of 23
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in-kind support in various ways, including staff time, facil-
ities, expertise and other support, as indicated in table 1.
Several other local organisations, such as community
organisations, workplaces, and high schools, also made
important contributions to the study, most commonly
through assisting in recruitment and providing facilities
for screening. Bayer HealthCare provided two urinalysis
machines and accompanying consumables.
Study principles
DRUID study partners committed to several core princi-
ples, including: developing and maintaining trust; Indige-
nous direction; employment, training and development
opportunities for Indigenous people; high quality
research methods; a transdisciplinary research focus;
openness to working in new and appropriate ways; evalu-
ation; and research transfer.
Ethics
The study was approved by the joint Menzies School of
Health Research – Northern Territory Department of
Health and Community Services Human Research Ethics
Committee. The project was considered and approved by
both the Aboriginal sub-committee, which has absolute
right of veto, and by the main committee.
Target population
The study was aimed at adults aged 15 years and over who
identified as Aboriginal and/or Torres Strait Islander, had
lived within a geographically defined area around Darwin
for at least 6 months, and who lived in a private dwelling
(i.e., who did not live in an institution, such as a hospital,
prison, boarding school or nursing home). The defined
area was an administrative region known as the Yilli Rre-
ung Aboriginal and Torres Strait Islander Commission
(ATSIC) Region. This region of approximately 10,355
square kilometres is located in the northwest corner of the
Northern Territory and includes the cities of Darwin and
Palmerston, and a rural hinterland with several small
towns and communities.
Based on data from the 2001 Census, the estimated resi-
dent Indigenous population (ERP) of the Yilli Rreung
ATSIC Region as at 1 July 2004 (the approximate mid-
point of the recruiting phase) included approximately
12,306 Indigenous people. This ERP figure takes into
account adjustments for people whose Indigenous status
was not stated, the estimated net census undercount, and
births, deaths and migration between the time of the Cen-
sus and the time of the estimate [8,9]. Of these estimated
12,306 Indigenous people, approximately 7,861 were
aged 15 years or more. The number living in private dwell-
ings is not known precisely, but it can be estimated using
data from 2001 Census counts. Approximately 89.7% of
those enumerated in the Yilli Rreung ATSIC Region were
enumerated in private dwellings [10]. If this figure is
applied to the Indigenous ERP, then approximately 7,051
people were potentially eligible based on age, Indigenous
status and type of dwelling. It is not known what propor-
tion of this group had lived within the Region for at least
six months; the true number of eligible people is likely to
be less than this figure.
Participant recruitment
One of the main barriers to the conduct of population-
based research in Australian Indigenous communities in
urban areas is the lack of a sampling frame from which to
select and contact potential participants. Indigenous peo-
ple are not identified as such in the lists traditionally used
in research, such as the electoral roll, telephone listings,
etc. Although some existing lists do include Indigenous
identification, these are usually incomplete and/or
include people from outside the area of interest (e.g. Abo-
riginal Health Services client lists). In any case, current pri-
vacy laws do not generally allow this information to be
provided to researchers. In discrete Indigenous communi-
ties (generally in remote areas), it is possible to draw a
sample based on total population lists and then exclude
the small proportion of non-Indigenous residents. In
most urban areas, by contrast, Indigenous people make
up a relatively small proportion of the population and
they are widely dispersed across the city.
Given the absence of a list from which to select a sample
of participants, and the apparent support for and interest
in the study at the time it was first proposed, it was
decided to attempt to recruit as many eligible people as
possible. Three main methods of recruiting participants
were identified during the initial planning of the study,
including: 1) recruiting through the local Aboriginal
Health Service; 2) using community and family networks
starting with members of the study's ISG and working out-
ward; and 3) contacting people through the Northern Ter-
ritory Department of Health and Community Services
(NTDHCS). A full-time recruitment officer was appointed
to assist in developing and implementing these and other
complementary strategies.
None of the three main recruitment methods was an
unqualified success. The Aboriginal Health Service (AHS)
was going through a prolonged period of instability, with
management problems, financial difficulties [11] and
high staff turnover. This made it difficult for the AHS to
deliver its core business. In such circumstances, it was not
surprising that engagement with the DRUID Study was
not its highest priority. Following repeated attempts to
ascertain how the DRUID Study could assist the AHS
while at the same time recruiting study participants, aPage 4 of 23
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eventually seconded to the AHS to provide part-time dia-
betes education at no cost while also recruiting partici-
pants for the study from among the general clinic
population.
The ISG members were mixed in their ability to recruit
participants through their community and family net-
works. Several members of the group did not themselves
participate in the study, while others referred scores of
participants. The members of the group, who were acting
in a voluntary capacity, are leaders in their communities;
as such, they face a large number of competing priorities
for their limited time and energy. It is also possible that
the long lead time between applying for and receiving
funding led to a diminution of the momentum among
this group. In any case, it was often difficult to ensure a
quorum at ISG meetings once the study was up and run-
ning.
Contacting potentially eligible people through the NTD-
HCS was also limited in its success, in large part because
of problems relating to out-of-date or incorrect addresses.
The NTDHCS maintains a Client-Master Index which
includes the name, Indigenous status and last known
address of all people who have accessed public health or
community services in the Northern Territory; this
includes being born in an NT public hospital. (Most hos-
pital services to Indigenous people in the NT are provided
by public hospitals; there is one small private hospital in
Darwin, but it has traditionally admitted relatively few
Indigenous patients.) Although study staff could not
legally access the Client-Master Index directly, it was
agreed that the NTDHCS would send a letter and informa-
tion packet on behalf of the DRUID Study to all people
who appeared to be eligible for the study, based on Indig-
enous status, age and residential address. Of 8,061 letters
sent out by NTDHCS, approximately 2,620 (33%) were
returned to sender. Of these, the majority (68%) were
reported as having moved. Others were returned to sender
due to an unknown or insufficient address (24%), were
unclaimed (7%), or the addressee was reported as
deceased (2%). It is highly likely that other letters did not
reach their intended destination and were destroyed
rather than returned, but it is impossible to be certain of
the magnitude. Several DRUID staff members who were
eligible to participate in the study did not receive one of
these letters.
A variety of other recruitment strategies was used through-
out the study, with varying degrees of success. Some of
these were aimed at increasing awareness of the study,
while others were aimed at securing actual participation.
A logo and slogan were designed, and a community
launch was held during the first month of screening, with
hundreds of key community members and organisations
invited. Information packets were sent to all general med-
ical practitioners and health centres in the area, explaining
the study and encouraging them to refer all Indigenous
patients. Booths were set up in major shopping centres,
health fairs, sporting venues and at community events.
Several newspaper ads were placed, especially at the
beginning and end of the recruitment period. A television
ad was made using a well-known local Indigenous musi-
cian. This was run as paid advertising on the main com-
mercial station and as a community service
announcement on both local commercial stations. A com-
plementary radio ad campaign was run in conjunction
with the television ads. Media releases were prepared to
coincide with several events, resulting in stories with pho-
Table 2: Analysis of blood and urine samples*
Test Anticoagulant Instrument Method principle
Glucose – fasting, 2 hour Fluoride/EDTA Hitachi 917 Enzymatic
Insulin – fasting, 2 hour Fluoride/EDTA Abbott Axsym Immunoassay
Homocysteine Fluoride/EDTA Agilent HPLC Fluorometric
Cholesterol None (serum) Hitachi 917 Enzymatic
Triglyceride None (serum) Hitachi 917 Enzymatic
HDL-cholesterol None (serum) Hitachi 917 Enzymatic
LDL-cholesterol N/A Calculated Calculated
Creatinine None (serum) Hitachi 917 Kinetic Jaffe
Hs-CRP None (serum) Hitachi 917 Immunoturbidimetry
HbA1c EDTA Agilent HPLC Cation exchange
Fibrinogen Sodium citrate IL Futura plus Clotting time
Urine albumin None (urine) Beckman Array 360 Immunonephelometry
Urine creatinine None (urine) Hitachi 917 Kinetic Jaffe
Urine ACR N/A Calculated Calculated
* Note: Analysis of fatty acids and carotenoids using frozen samples is also planned. This is expected to occur in 2006. Methods will be described 
elsewhere.Page 5 of 23
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and radio interviews. Information was also sent to the
newsletters of sporting clubs and associations, employ-
ment groups and community organisations.
Translating general awareness of the study into either par-
ticipation or a clear refusal to participate was especially
challenging due to the lack of a list of names and contact
details. Staff members entered potentially eligible people
known to them into a database, but the number of entries
fell far short of the estimated number eligible. Attempts
were made to contact all those listed in the database by
telephone or letter, but many could not be reached. Door-
knocking was conducted in the two areas with the highest
proportion of Indigenous residents, but this resulted in
few completed appointments and was not continued.
Greater success was achieved through a series of visits to
workplaces, high schools and discrete Indigenous com-
munities, including town camps and small settlements.
An estimated 40% or more of all participants were
recruited through such visits. Recruitment and screening
were conducted at approximately 20 workplaces (prima-
rily NT and Australian Government agencies and commu-
nity service organisations), five high schools, and nine
discrete communities. The NT Public Service Commis-
sioner agreed that eligible staff in NT Government depart-
ments could participate in the study during work time
without loss of pay; other workplaces appeared to adopt a
similar policy. Some supportive individuals took advan-
tage of the study's offer to host family events as part of
recruitment. Family members were invited to participate
in screening at their relative's house, followed by a barbe-
cue with food supplied by the study.
Staffing and training
A total of 18 different individuals were employed on con-
tracts over the course of the baseline phase of the study. Of
these, 13 were Indigenous and 5 were non-Indigenous.
Additional people were employed on a casual basis dur-
ing visits to discrete communities; these community
members acted as local facilitators. An Aboriginal Eye
Health Worker from the local Aboriginal Health Service
was seconded to the study during follow-up screening
among participants with diabetes (approximately 1 day a
month). Three post-graduate research students (one of
whom is Indigenous) also participated in the study, with
one substantially involved in data collection, and the
other two participating in a more limited way.
All DRUID staff members who had access to data col-
lected in the study were required to sign a confidentiality
pledge. This pledge states that the person who signs it is
aware of the sensitive and confidential nature of the infor-
mation, and that he or she understands that inappropriate
use of the information will be grounds for immediate dis-
ciplinary action, which may include termination of
employment. This pledge was based on that used in the
Strong Heart Study in the US [12].
A DRUID Study staffing and recruitment strategy was
developed in conjunction with the ISG. In addition to tra-
ditional recruitment methods such as newspaper advertis-
ing, information on the positions available was sent for
wide distribution to all ISG members as well as to a
number of local community organisations and govern-
ment departments. Secondments and flexible working
arrangements were strongly encouraged, but these were
not taken up. ISG members participated in drafting the
position descriptions, and every selection panel included
at least one member of the ISG.
Twelve staff were hired and trained together just prior to
the start of data collection. Four staff had previously com-
pleted an Aboriginal Health Worker course, one was a
nurse, and one had a certificate in laboratory skills. The
others came from a variety of non-health backgrounds.
With the exception of the project manager, none of the
Table 3: Analysis of blood samples for PCOS sub-study
Test Preservative Instrument Method principle
Testosterone Lithium heparin n/a RIA (radioimmunoassay)
Sex-hormone binding globulin SHBG Lithium heparin n/a IRMA (immunoradiometric assay)
Free androgen index (FAI) N/A Calculated Calculated
Free testosterone N/A Calculated Derived from mass equations
17-hydroxyprogesterone (17-OHP)* Lithium heparin n/a RIA (radioimmunoassay)
Prolactin* Lithium heparin Centaur ICLMA (immunochemiluminometric assay)
Thyroid stimulating hormone (TSH)* Lithium heparin Centaur ICLMA (immunochemiluminometric assay)
* These additional tests were performed for women with oligomenorrhoea plus at least one of the following: a positive questionnaire response to a 
question on problems with acne; a positive questionnaire response to a question on problems with hair; or FAI of 5.5 nmol/L or more. Women 
were categorised as having oligomenorrhoea if they reported irregular menses or reported that their menstrual cycles were either less than 24 days 
long or 35 or more days long. (Women who were post-menopausal or had undergone a hysterectomy were excluded.) All women in this group are 
currently being followed up as part of the PCOS sub-study.Page 6 of 23
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school. Only one staff member other than the project
manager had previous research experience.
Training consisted of both on-the-job and formal train-
ing. This began with a one-week structured orientation/
induction program including basic training in research
methods and in diabetes understanding, followed by one
week of specific role-based training. Staff were classified as
having clinical, laboratory, interviewer or administrative
responsibilities and were provided training relevant to
these areas.
One of the activities included during the initial training
program was the production of a video about the study.
This video was used during the consent process and
showed potential participants what would be involved,
should they choose to take part. The successful produc-
tion of the video required the actors (DRUID staff mem-
bers) to learn to perform their study tasks to an adequate
standard. This provided incentive to learn the material
being presented to them during didactic instruction. Dur-
ing this same time, staff members also participated in dis-
cussions about suitable logos and slogans for the study
and provided feedback on the data collection forms.
Table 4: Topics included in DRUID Study questionnaires
Topic Questionnaire Version*
1 2
Age and date of birth Yes Yes
Sex Yes Yes
Indigenous group Yes Yes
Time fasting Yes Yes
Whether pregnant Yes Yes
Whether previously tested for diabetes Yes Yes
Self-reported diabetes status Yes Yes
Current diabetes treatment (if applicable) Yes Yes
Usual health care provider Yes Yes
Medical history Yes Yes, but reduced
Diabetes care Yes No (but a few questions moved to diabetes complications form)
Dental health Yes No
Health insurance Yes Yes, but reduced
Alcohol use Yes Yes, but reduced and some questions changed
Smoking Yes Yes, but reduced and some questions changed
Physical activity Yes Yes, but reduced and some questions changed
Weight and nutrition Yes Yes
Subjective social status [21] Yes No
Household characteristics Yes Yes, but reduced
Education Yes Yes, but reduced
Employment Yes Yes, but reduced
Income Yes Yes, but reduced
Culture and identity Yes Yes
General health and wellbeing (SF-12) [22] Yes First question only
Stress Yes No
Discrimination Yes No
Depression (CES-D) [23] Yes No
Control Yes No
Social support [24] Yes No
Optimism/pessimism (LOT-R) [25] Yes No
For women only:
Menstrual history Yes N/A§
Contraceptive use Yes N/A§
Pregnancy Yes N/A§
Infertility Yes N/A§
Hysterectomy Yes N/A§
Menopause Yes N/A§
Hormone replacement therapy Yes N/A§
* Version 1 was administered to participants with an ID less than or equal to 400. Version 2 was administered to subsequent participants.
§ The women's reproductive health questionnaire remained unchanged (i.e. Version 1), but administration was limited to women aged 45 years and 
under.Page 7 of 23
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supported to undertake additional training activities. For
example, several staff completed a venipuncture certifica-
tion course (including two who did not previously have
clinical responsibilities), one enrolled in a post-graduate
diabetes educator course, another in a Certificate 3 labo-
ratory skills course, and another in undergraduate science
units. Staff also attended a local conference on chronic
disease as a group. Other informal training, mentoring
and support were provided to all staff. Support for many
of these additional training activities was provided by the
Australian Government Department of Employment and
Workplace Relations, through a Structured Training and
Employment Project funded as part of the Government's
Indigenous Employment Strategy.
The original staff members were hired on one-year con-
tracts. This caused difficulty when recruitment was much
slower than anticipated, because the contracts could not
be shortened or terminated. With the exception of the ini-
tial project manager (who decided to pursue a PhD), staff
who left the team prior to the expiry of their contracts
were not replaced. These departures occurred for a variety
of personal, health and performance related reasons.
Consent
Potential participants were provided with written infor-
mation about the study, invited to watch a video detailing
what was involved, and given an opportunity to ask ques-
tions. Those who indicated that they wished to participate
were then asked to complete and sign a consent form. A
parent or guardian was asked to sign the form as well if the
participant was under 18 years old.
Participants were asked to give separate consent for vari-
ous elements of the study, including: questionnaires; fast-
ing blood sample; 2-hour oral glucose tolerance test; urine
sample; body measurements; blood pressure; and cardio-
vascular measurements. They were also asked to indicate
the preferred method of contact (telephone or post) for
their individual results, and whether they wanted a report
sent to a primary health care provider (and if so, which
one).
Participants were requested to select one of three options
regarding the long-term storage of excess blood and urine
samples: 1) destroy all remaining samples after comple-
tion of baseline tests; 2) store any remaining samples, but
contact the participant to seek permission if a researcher
wishes to use them in the future; 3) store any remaining
samples, and use them without contacting the participant,
provided their use is approved by the ISG and the relevant
ethics committee(s).
Permission was also sought to obtain information about
participants from other data sources, including: their
health care provider(s); pathology services; the NT
Department of Health and Community Services (for pub-
lic hospital admissions); the Darwin Private Hospital; and
the NT Registrar of Births, Deaths and Marriages and the
National Death Index. This was necessary because of pri-
vacy legislation governing the secondary use of data from
these sources.
The consent form indicated that study staff would contact
participants in future years to update their contact details
and to collect limited additional data on health and use of
health services. Participants were asked to provide permis-
sion to contact their family and/or friends to help us find
them in the future. This was intended to reduce suspicion
and unwillingness to provide information by indicating
the person's wishes to his or her family and friends.
We also asked participants whether they would be willing
to have the study team contact them in the future: 1) to
invite them to participate in a continuation of the current
study beyond the initial five years; and 2) to discuss other
related studies that have been approved by the study's ISG
and by the relevant ethics committees.
Participants with diabetes who were invited to participate
in additional tests for diabetes complications (described
below) were asked to complete a second consent form.
This form asked them to agree to participate in the various
components of the complications assessment, including
an eye examination, foot examination, blood pressure
measurements, echocardiograph, and questionnaire. They
were also asked to indicate how they wished to receive
their results and whether they wanted a report sent to a
health care provider (and if so, which one).
Examination protocol
Following confirmation of contact details and eligibility,
and after obtaining informed consent, a health examina-
tion was undertaken. This examination included: collec-
tion of blood and urine samples; clinical and
anthropometric measurements; and the administration of
questionnaires. The examination required a minimum of
2.5 hours for most participants, and was followed by a
light lunch. After the examination was completed, partic-
ipants were asked to provide contact details for any
friends and relatives who might be interested in partici-
pating in the study.
People with diabetes were invited to return on a later day
for additional tests, including examination of the eyes and
feet, additional blood pressure measurements, an
echocardiograph and additional questions relating to thePage 8 of 23
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8management and complications of diabetes. This exami-
nation took approximately 30–45 minutes.
In order to determine the participant's fasting status and
whether an oral glucose tolerance test was required, a few
screening questions were asked regarding time since the
person had last eaten, whether pregnant (females), and
whether currently using insulin and/or tablets for diabe-
tes. Oral glucose tolerance tests were not conducted on
pregnant women or those currently using insulin and/or
tablets for previously diagnosed diabetes. Those who had
not fasted for at least 10 hours were asked to return on
another day.
A) Blood and urine samples
For participants who reported fasting for at least 10 hours,
a fasting blood sample was drawn, with up to 4 tubes (up
to 13 ml) of blood collected. Immediately following this,
participants were given a 75 ml glucose drink (Scot Scien-
tific Pty Ltd, Welshpool, WA, Australia) unless they were
currently taking tablets and/or insulin for previously diag-
nosed diabetes, were pregnant, or did not consent to this
part of the study. A second blood sample (approximately
2 ml) was collected 2 hours later.
A urine sample was collected during the visit, at a time of
the participant's choosing. Urine samples were sent away
for analysis as described below. In addition, local dipstick
testing of urine was introduced after the first few months
of recruitment to establish whether a urinary tract infec-
tion was present at the time of the examination. Dipstick
testing was performed using Multistix 10SG multiple rea-
gent strips (Bayer Australia Ltd, Pymble, NSW, Australia)
and a urine chemistry analyser (either a Clinitek 50, Bayer
Corporation, Elkhart, IN, USA or a Clinitek Status, Bayer
HealthCare Diagnostics Division, Sudbury, Suffolk, UK).
Participants with urine that was dipstick-positive for leu-
cocytes, nitrites and/or blood were asked for permission
to send a midstream urine sample to a local pathology
service for further testing, with results provided to the
Sex distribution: DRUID participants versus two comparison groupsFigure 1
Sex distribution: DRUID participants versus two comparison groups. Comparison of DRUID participants with the 
2004 Indigenous estimated resident population of the Yilli Rreung ATSIC Region [9] and with potentially eligible Indigenous cli-
ents from the Northern Territory Department of Health and Community Services' (NTDHCS) Client-Master Index.
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8DRUID study. If positive, both the participant and his or
her general medical practitioner were notified. Some par-
ticipants declined to give permission for further urine test-
ing; they were asked to see their primary health care
provider for follow-up.
Blood and urine samples were labelled, processed, frozen,
and shipped to the Clinical Trials Laboratory at Flinders
Medical Centre (Bedford Park, South Australia) for analy-
sis. The instruments and analytical methods used were as
shown in table 2.
Blood samples were stored on ice until centrifuged. With
the exception of HbA1c (for which whole blood was
used), all blood and urine was spun by centrifuge at 3000
RPM for 15 minutes. Whenever possible, blood samples
were spun within one hour of collection.
As part of a sub-study on polycystic ovary syndrome
(PCOS), an additional blood sample was collected, gener-
ally as part of the fasting sample, for females aged 45 years
and under. These samples were processed in the same way
as the other blood samples (as described above), but they
were sent to the Repromed Laboratories (University of
Adelaide, South Australia). Details on assays and analytic
methods are shown in table 3.
B) Clinical and anthropometric measurements
Clinical measurements included blood pressure and pulse
rate and, for participants aged 25 years and over, an elec-
trocardiogram. Anthropometric measures included
height, weight, waist circumference and hip circumfer-
ence. No anthropometric measurements were taken for
participants in wheelchairs, and only height was meas-
ured for pregnant women.
Blood pressure was measured three times after the partic-
ipant had been seated quietly for at least 5 minutes. A
Welch Allyn Spot Vital Signs monitor (Welch Allyn Medi-
cal Products, Skaneateles Falls, USA) was used to measure
systolic and diastolic pressure, with one minute between
readings. The pulse rate from the second reading was also
recorded. For every twentieth participant, an additional
measurement of blood pressure was taken using the aus-
Age distribution: DRUID participants versus two comparison groupsFigure 2
Age distribution: DRUID participants versus two comparison groups. Comparison of DRUID participants with the 
2004 Indigenous estimated resident population of the Yilli Rreung ATSIC Region [9] and with potentially eligible Indigenous cli-
ents from the Northern Territory Department of Health and Community Services' (NTDHCS) Client-Master Index (CMI).
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8cultatory (manual) technique. For these participants,
manual and automatic measurements were done in alter-
nating order.
An electrocardiogram (ECG) was performed on partici-
pants aged 25 years and over using a Philips PageWriter
10i handheld 12-lead electrocardiograph with automatic
interpretation (Philips Medical Systems, Andover, MA,
USA). ECG tracings were evaluated and coded in a single
batch by a trained and certified Minnesota coder.
Some participants aged between 30 and 60 years were part
of a special sub-study involving measurement of carotid
intima media thickness using ultrasound, and of arterial
stiffness using pulsewave analysis. These methods will be
described elsewhere.
Height in centimetres was measured using a portable sta-
diometer (Model PE87, Mentone Educational Centre,
Moorabbin, Victoria, Australia). Participants were shoe-
less and wore light clothing. They were instructed to stand
facing forward with weight distributed evenly on both
feet, with heels together and against the wall and arms
hanging loosely by their sides. The participant's head was
positioned so that the Frankfort Plane was horizontal. The
participant was then instructed to keep his or her eyes
focused on a point straight ahead, breathe in deeply, and
stretch to his or her fullest height, with heels still on the
ground. The measuring plate was then lowered onto the
scalp until it rested firmly on the top of the head and a
reading to the nearest 0.1 cm was obtained and recorded.
Following the measurement of weight (as described
below), a second height measurement was obtained and
recorded, again to the nearest 0.1 cm. If the two height
measurements differed by more than 0.5 cm, a third
measurement was taken and recorded.
Weight in kilograms was measured using a Seca digital
portable scale (Model 767, Seca Deutschland, Hamburg,
Germany). Participants were asked to remove shoes,
heavy garments, heavy jewellery, belts, loose change, keys,
mobile phones, and other items from pockets. With the
scales at zero, participants were asked to stand on the cen-
tre of the base with feet together, arms hanging loosely at
Age distribution of males: DRUID participants versus Yilli Rreung residentsFigure 3
Age distribution of males: DRUID participants versus Yilli Rreung residents. Comparison of DRUID participants 
with the 2004 Indigenous estimated resident population of the Yilli Rreung ATSIC Region [9].
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8the sides and the head facing forward. Weight was
recorded to the nearest 0.1 kilogram.
Waist and hip circumference were measured in centime-
tres using a 2-metre non-stretch fibreglass tape. Following
removal of outer clothing, tight-fitting garments, belts and
heavy items from pockets, participants were asked to
stand comfortably erect in a relaxed manner, breathing
normally, with weight balanced evenly on both feet, feet
about 25–30 cm apart, and arms folded across the chest.
Waist and hip measurements were taken alternately, with
a minimum of two measurements for each. All measure-
ments were taken and recorded to the nearest 0.1 centime-
tre. If the first two measurements of either waist or hip
circumference differed by more than 1.0 cm, then a third
measurement was taken for waist or hip, as relevant. Waist
measurements were taken directly on the participant's
skin if possible, or over at most one layer of clothing. Hip
measurements were taken over the participant's clothing,
unless it was too tight or too baggy, in which case the par-
ticipant was asked to remove it.
The waist was defined as the midway point between the
iliac crest and the costal margin. These two landmarks
were identified and marked using a felt tip pen, and the
distance between them measured, with the midpoint
marked. Once the tape was around the participant's body
at the appropriate height and the tape was horizontal, the
participant was asked to breathe out gently. The measure-
ment was taken at the end of a normal expiration, with the
tape pulled snug but not compressing the underlying soft
tissue.
The hip circumference was defined as the widest circum-
ference over the buttocks and below the iliac crest. The hip
circumference was measured at several positions (starting
with the widest part of the buttocks when viewed from the
side) and the widest circumference recorded. Fatty aprons
were not included in the measurement of the hips. The
measurement was taken with the tape in a horizontal
position, and the tape was pulled to allow it to maintain
its position without causing indentation.
Age distribution of females: DRUID participants versus Yilli Rreung residentsFigure 4
Age distribution of females: DRUID participants versus Yilli Rreung residents. Comparison of DRUID participants 
with the 2004 Indigenous estimated resident population of the Yilli Rreung ATSIC Region [9].
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Questionnaires covered a range of topics, as indicated in
table 4. Questionnaires were originally interviewer-
administered due to concerns about English literacy in the
target population, but many participants indicated that
they preferred to read the questions themselves. Forms
were revised after the first three months to allow either
self-administration or interviewer administration. No
changes to content or question wording were made at that
time. A coding system was already in use to record the
identification of the administrator, using unique DRUID
interviewer codes; a new code was assigned to indicate
self-administration.
In response to concerns about slower-than-anticipated
recruitment, modifications were made to the question-
naires after the study had been underway for approxi-
mately six months. For participants assigned an ID
number less than or equal to 400, three questionnaires
covered the following areas: 1) General medical history
and risk factors; 2) Psychosocial factors; 3) Women's
reproductive health (females only). After six months, the
first two questionnaires were shortened and combined
into one form. The content of the women's reproductive
health questionnaire was unchanged, but administration
was limited to women aged 45 years and under.
Approximately 40% of Questionnaire 1 (Version 1) and
Questionnaire 2 (Version 1) were self-administered. This
increased to 91% of the combined Version 2 Question-
naire. About 79% of women's reproductive health ques-
tionnaires were self-administered.
D) Additional tests for people with diabetes
Participants with diabetes, either previously known or
newly diagnosed through the study, were invited back for
an additional set of tests relating to diabetes complica-
tions. For the purposes of this study, a participant was
Area of residence: DRUID participants versus two comparison groupsFigure 5
Area of residence: DRUID participants versus two comparison groups. Comparison of DRUID participants with 
2001 Census counts for Indigenous residents of the Yilli Rreung ATSIC Region [10] and with potentially eligible Indigenous cli-
ents from the Northern Territory Department of Health and Community Services' (NTDHCS) Client-Master Index (CMI). 
DRUID and NTDHCS figures exclude people with missing or ineligible postal codes.
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8considered to have diabetes if: a) he or she reported a pre-
vious physician diagnosis of diabetes and was currently
taking tablets and/or insulin; or b) his or her blood test
results indicated glucose levels consistent with diabetes
(i.e. fasting glucose greater than or equal to 7.0 mmol/L
and/or 2-hour glucose greater than or equal to 11.1
mmol/L).
Diabetes complications screening sessions were held
approximately every other month. Some participants
attended the first session following their initial health
examination, others attended only after several months of
broken appointments and numerous reminder calls, and
some declined to participate in this part of the study.
The complications assessment consisted of a question-
naire, a clinical examination, and an eye examination. The
questionnaire covered the following topics: age at diagno-
sis, diabetes care provider, history of amputations, history
of foot ulcers, signs and symptoms in the legs and feet
(including the Edinburgh Claudication Questionnaire
[13] and the Neuropathy Symptom Score [14]), most
recent foot exam, use of footwear, use of specified medi-
cations, and history of eye problems related to diabetes.
The clinical examination included inspection for foot
ulcers, assessment of ankle reflexes and sensation in the
great toes [14], pressure perception threshold at three sites
on each foot [15], lying and standing blood pressure [16],
and measurement of ankle brachial pressure index [17].
Assessment of ankle reflexes was performed using a stand-
ard reflex hammer. Reflexes were examined with the par-
ticipant kneeling on a chair. If reflexes were absent then
the assessment was repeated with reinforcement (the par-
ticipant gripping the chair & gritting his or her teeth at the
same time). Reflexes were classified as normal, present
with reinforcement or absent.
Vibration perception (on the great toes) and temperature
perception (on the dorsal surface of the metatarsal heads)
were assessed using a standard 128 Hz tuning fork. Pin-
prick perception was assessed on the dorsal surface of the
great toes using a sterile neurological examination pin
Indigenous group: DRUID participants versus Yilli Rreung residentsFigure 6
Indigenous group: DRUID participants versus Yilli Rreung residents. Comparison of DRUID participants with 2001 
Census counts for Indigenous residents of the Yilli Rreung ATSIC Region [10].
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8(Neurotips, Owen Mumford, Woodstock, Oxford, Eng-
land). Participants were tested with their eyes closed.
Pressure perception threshold was measured using a 10 g
monofilament at the great toe, first metatarsal head and
fifth metatarsal head on the plantar surface of each foot.
Participants were tested with their eyes closed. The order
of sites was varied from participant to participant.
Lying and standing blood pressure were measured using a
manual anaeroid sphygmomanometer (Welch Allyn Med-
ical Products, Skaneateles Falls, USA). Systolic and diasto-
lic pressures were measured at the brachial artery in the
right arm while the participant was in a supine position,
after lying down for at least 5 minutes. The measurements
were repeated one minute after standing.
Ankle brachial pressure index was measured with the par-
ticipant in a supine position. Systolic arm pressure was
measured at the brachial artery using a Doppler probe
(Dopplex High Sensitivity Pocket Doppler Model D900,
Huntleigh Healthcare Pty Ltd, Hamilton Hill, WA, Aus-
tralia) and an anaeroid sphygmomanometer (Welch Allyn
Medical Products, Skaneateles Falls, USA). This was fol-
lowed by Doppler measurement at the dorsalis pedis or
posterior tibial artery of the foot.
The eye examination included measurement of visual acu-
ity and digital retinal photography. Visual acuity was
measured using a standard 6-metre wall-mounted Snellen
eye chart (BOC Ophthalmic Instruments, Pty Ltd, Silver-
water, NSW). Participants were tested as they presented,
i.e. wearing their glasses or contact lenses if they wore
them to the testing site. Pinhole testing was performed for
those whose presenting visual acuity was worse than 6/6,
but who were able to at least count fingers. Digital retinal
photographs were taken by a trained Aboriginal Eye
Health Worker using a Topcon non-mydriatic retinal cam-
era (Model TRC-NW5, Topcon Corporation, Tokyo,
Japan). Photographs were taken in two fields per eye
(macula centred and nasal to disc). In some cases, eye
drops were required to dilate pupils in order to obtain a
good image; this was noted. Photographs were graded by
a single ophthalmologist at the Centre for Eye Research
Australia (Melbourne, Australia). If photos could not be
obtained (usually because the participant declined or
because the Eye Health Worker was not available), the
participant was asked to provide consent for the study
Comparison of DRUID participants and Indigenous Yilli Rreung residents counted at the 2001 Census: weekly household incomeFigur  7
Comparison of DRUID participants and Indigenous Yilli Rreung residents counted at the 2001 Census: weekly 
household income. Comparison of DRUID participants with 2001 Census counts for Indigenous residents of the Yilli Rreung 
ATSIC Region [10]. Figures are in Australian dollars.
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8team to obtain recent results from the relevant eye care
provider.
An echocardiogram was performed as part of a sub-study
on selected participants aged between 25 and 64 years old.
The methods will be described elsewhere. Measurement
of urinary albumin-creatinine ratio (ACR) and glycated
haemoglobin were performed during the initial stage of
the study; most participants with diabetes also underwent
an ECG, as they were 25 years or older. These tests and
measurements were not repeated during the second visit.
Provision of individual results
The provision of individual results was an important part
of the study's relationship with the community. Some
feedback was provided at the time of testing, and some
participants, such as those with very high blood pressure
or with chest pains plus an abnormal ECG, were referred
immediately to the appropriate health care provider.
DRUID clinical staff also maintained a list of primary care
providers for participants who reported that they did not
have a usual care provider. Before the first individual
results were sent, all local medical practitioners identified
by the Top End Division of General Practice were pro-
vided with information on what the reports would con-
tain, as well as information on when, how and where to
refer patients with abnormal results and how to use rele-
vant Medicare item numbers. This information was
designed with the assistance and input of local medical
specialists.
A packet containing individual results was provided to
each participant once his or her blood and urine results
were received from the Clinical Trials Laboratory. Partici-
pants received their own values for height, weight, body
mass index, waist circumference, self-reported smoking
status, blood pressure, total cholesterol, triglycerides,
HDL cholesterol, urine ACR, glomerular filtration rate
(GFR), and fasting and two hour glucose values (and
HbA1c for people with previously diagnosed diabetes),
along with a description of what the test or measurement
indicated, the range of normal values and a comment on
their own scores. Participants also received health educa-
tion materials tailored to their specific results. With the
participant's consent, a report was also sent to the person's
primary health care provider. Whenever possible, partici-
pants with abnormal results were first contacted by tele-
phone or in person. The results packet was then mailed or
Proportion of DRUID participants reporting previously diagnosed diabetes, by ID numberFigure 8
Proportion of DRUID participants reporting previously diagnosed diabetes, by ID number.
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8hand-delivered, as appropriate. Some results were not
able to be delivered because the participant had moved or
could otherwise not be located.
People who participated in the assessment of diabetes
complications were provided with information about
their foot examination on the day of testing. They also
received information about diabetes and its complica-
tions from staff, including an endocrinologist specialising
in diabetes and a diabetes educator. Participants received
a letter indicating their eye results once the grading of ret-
inal photographs was completed. With the participant's
consent, a report on the complications assessment was
sent to the participant's primary care provider and/or dia-
betes care provider. This report included information on
foot ulcers, amputations, pressure perception threshold
test, ankle brachial pressure index, urine ACR and GFR
(from the initial examination), visual acuity, and retinop-
athy grading.
Data handling and statistical methods
Information about potential participants was entered into
specially modified business contact tracing software
(Goldmine Business Contact Manager Edition with
GoldSync, Version 6.0.21021, FrontRange Solutions Inc.,
Colorado Springs, CO, USA). Although it was intended to
use this software for all appointment booking, recruit-
ment activities and participant contact, the relative lack of
intermediate-level computing skills within the team
meant that the potential of this system was not fully real-
ised.
All data other than name and contact details were entered,
using a combination of manual entry and optical scan-
ning, into a custom-designed Oracle database (Oracle
NET8, Oracle Corporation, Redwood City, CA, USA) with
a Microsoft Access front end. Anthropometric and clinical
measurements were entered manually from the relevant
recording form, as were responses to all questions on the
consent forms. All questionnaires were scanned using
Remark Office OMR® version 5.5 software (Principia Prod-
ucts, Paoli, PA, USA) and a high-speed duplex colour
image scanner (Fujitsu fi-4120C, Fujitsu Australia Ltd,
North Ryde NSW, Australia). Blood and urine results and
retinal grading were provided by the relevant laboratory
in spreadsheets and uploaded directly to the Oracle data-
base. All data will be subjected to a range of assessments
relating to completeness, accuracy, and plausibility. Once
Proportion of DRUID participants with hypertension, by ID numberFigure 9
Proportion of DRUID participants with hypertension, by ID number. Hypertension includes measured blood pres-
sure greater than or equal to 140/90 mm Hg and/or reported as currently taking antihypertensive medications.
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created.
All statistical analysis will be performed using the latest
available release of Stata software (Stata Corporation, Col-
lege Station, TX). Techniques will vary according to the
specific analysis, but will primarily involve multivariate
linear or logistic regression.
Study participants
Between 12 September 2003 and 31 March 2005, a total
of 1,033 Indigenous residents of the Yilli Rreung ATSIC
Region completed a consent form. Twenty-four of these
participants were ineligible due to length of residency or
age and were excluded from further consideration: 16
indicated that they had lived in the area for less than 6
months, and a further 8 high school students had not yet
turned 15 years old. Study staff also tested 7 Indigenous
people who were not residents of Yilli Rreung and 28 non-
Indigenous volunteers (12 as part of initial training and
another 16 who were mostly family members of Indige-
nous participants or DRUID staff members). The tests of
people known to be ineligible were done in certain cir-
cumstances to promote a positive image of the study and
to increase awareness of diabetes.
Of the 1,009 eligible participants who gave consent, 1,004
provided at least one measurement. The numbers of eligi-
ble participants who provided selected information was as
follows: consent – 1,009; fasting blood sample – 945; oral
glucose tolerance test – 815; urine sample – 910; ques-
tionnaire 1 (version 1 or 2) – 920; questionnaire 2 (ver-
sion 1) – 312; women's reproductive health questionnaire
– 441 (women aged 45 years and under); blood pressure
– 996; height – 969; weight – 965; waist circumference –
938; and hip circumference – 935. Of the 175 participants
eligible for complications assessment, 138 were exam-
ined.
Comparison of participants with other estimates of the 
target population
The 1,009 eligible people who completed a consent form
represent approximately 14.3% of the estimated 7,051
people who were potentially eligible as at 1 July 2004 (the
approximate midpoint of the recruitment period). Infor-
mation on sex, age group, area of residence, Indigenous
Proportion of DRUID participants with body mass index of 30 or more, by ID numberFigure 10
Proportion of DRUID participants with body mass index of 30 or more, by ID number.
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BMC Public Health 2006, 6:8 http://www.biomedcentral.com/1471-2458/6/8status and household income was compared for DRUID
participants and for Yilli Rreung residents, based on data
from the 2001 Census and from the NTDHCS Client-Mas-
ter Index. This is presented in the following figures.
As shown in figure 1, the proportion of females participat-
ing in the DRUID Study was substantially and signifi-
cantly higher (p < 0.001) than the proportion in the
Indigenous population of the Yilli Rreung region as esti-
mated in 2004. It was also significantly higher (p < 0.001)
than in the group identified as potentially eligible in the
NTDHCS Client-Master Index.
The age distribution was also significantly different in the
DRUID Study than in the Yilli Rreung population in 2004
(p < 0.001) or the NTDHCS Client-Master Index (p <
0.001), with fewer than expected participants in the
younger age groups (figure 2). Unlike the DRUID Study,
the Yilli Rreung ERP and the NTDHCS group include peo-
ple in non-private dwellings. Institutions such as board-
ing schools and prisons tend to include younger people,
and this could explain at least some of the differences in
age structure. The difference among males was relatively
small except among those aged 25–34 years (figure 3),
and was not significantly different (p = 0.065). Among
females (figure 4), the difference (p < 0.001) was most
marked among those aged 15–24 years.
The distribution by place of residence was similar for
DRUID Study participants and the Yilli Rreung Indige-
nous ERP (figure 5), although the small differences seen
were statistically significant (p = 0.028) due to the large
numbers in the population. The distribution of the NTD-
HCS Client-Master Index was somewhat different from
the other two groups. This may reflect the fact that the Yilli
Rreung ERP is based on place of residence, while the NTD-
HCS group is categorised by mailing address. The DRUID
Study group reflects a combination of residential and
mailing addresses.
The proportion of DRUID participants reporting sole
Aboriginal identification was slightly lower than in the
Yilli Rreung ERP, while the proportion reporting mixed
(Aboriginal and Torres Strait Islander) origin was higher
(figure 6). Although the differences were small, they were
statistically significant (p = 0.001).
The distribution of weekly household income was also
significantly different (p = 0.002), but not in any system-
atic way (figure 7). Some of the difference may reflect
Proportion of DRUID participants reporting current smoking, by ID numberFigure 11
Proportion of DRUID participants reporting current smoking, by ID number.
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Census (Yilli Rreung population) and those reported at
the time of the DRUID Study in 2003–2005. The high
proportion of people who did not provide a response
makes comparisons somewhat difficult.
It is not possible to know whether the health status of
DRUID Study participants was different from that of non-
participants. There is some evidence to suggest that the
health status of participants varied over the course of the
study, with early participants significantly more likely (p
= 0.001) to report previously diagnosed diabetes (figure
8). This is likely to reflect a widely held belief early in the
recruitment period that the study was intended for people
with diabetes, rather than for the population as a whole.
Subsequent publicity about the study was designed to
emphasise the importance of broad participation, and
there was no significant difference by ID number in the
proportion with previously diagnosed diabetes among
those with an ID number greater than 200 (p = 0.297).
As shown in figures 9 and 10, early participants were also
significantly more likely to have hypertension (either
measured blood pressure greater than or equal to 140/90
mm Hg, or currently taking antihypertensive medications;
p < 0.001) and to have a body mass index classified as
obese (p = 0.001). After excluding the first group of 200
ID numbers, there was no difference in the proportion
with hypertension according to ID number (p = 0.982).
There remained a significant difference in the proportion
categorised as obese (p = 0.015), but in absolute terms,
this difference was small.
The proportion of participants who reported they were
current smokers was high as expected, and did not vary
significantly over the course of the study (figure 11; p =
0.700).
The proportion of males was not significantly different (p
= 0.246) for earlier and later participants (figure 12), but
there was a marked increase in the proportion of people
aged 15–24 years old among later participants (figure 13;
p < 0.001). This is due to the inclusion of several high
schools during the last few months of recruitment.
Discussion
Population health research involving Indigenous Austral-
ians has long been a challenging endeavour [18-20], and
the DRUID Study is no exception. Despite apparent com-
munity support, interest and involvement in the study,
Proportion of DRUID participants who were male, by ID numberFigure 12
Proportion of DRUID participants who were male, by ID number.
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As a result, we were unable to meet all of the initial aims
of the study.
Our success in meeting our aim of providing the first accu-
rate assessment of the burden of diabetes, diabetic com-
plications and associated chronic diseases in an urban
Indigenous population depends on how well the study
participants represent the population of interest. Partici-
pants were not substantially different from the population
of interest with respect to demographic features other
than sex. Although there were statistically significant dif-
ferences between study participants and the Yilli Rreung
Indigenous estimated resident population in the distribu-
tions by age, sex, area of residence, Indigenous group and
household income, these differences were small in abso-
lute terms, with the notable exception of sex. In addition,
the Yilli Rreung ERP includes people living in non-private
dwellings, who were not eligible to participate in the
study. This inclusion may explain some of the differences
in the distributions between the two groups. In any case,
it highlights the importance of using caution when inter-
preting such comparisons. The Australian Bureau of Statis-
tics (ABS) does not produce a separate ERP figure for the
Indigenous population in private dwellings, so the only
other option using ABS data is to use census counts of
people in private dwellings as the basis of comparison.
However, unlike the ERP figures, these counts do not take
into account people who were not included in the Census
or who did not respond to the question on Indigenous
status, and the figures are only available for years in which
a census was conducted. As with the ERP, these factors
could have an impact on the distributions of interest.
Comparisons using the NTDHCS Client-Master Index
must also be made with caution, given the high rate of let-
ters returned to sender, and the fact that several eligible
staff members did not receive a letter.
The representativeness of the health status of participants
is unknown. Early participants were clearly more likely
than later participants to have a history of chronic health
problems, such as a previous diagnosis of diabetes and
hypertension. However, after the first 200 participants,
the rates generally stabilised, which may indicate that par-
ticipation was independent of health status during most
of the study. In addition, the proportion of participants
who reported they were current smokers was stable
throughout the study, which does not suggest any differ-
ence in health risk factor profiles, at least for one impor-
tant health behaviour.
Proportion of DRUID participants in the age group 15–24 years, by ID numberFigure 13
Proportion of DRUID participants in the age group 15–24 years, by ID number.
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can not be interpreted as true population prevalences,
they may still provide useful – albeit approximate and
possibly somewhat biased – estimates. In any case, few
alternative estimates are currently available for any urban
Indigenous populations in Australia, and none exist for
the Darwin region. Perhaps more importantly, the exten-
sive data collected in the study will also be used to exam-
ine relationships among variables of interest. These data
will provide information that is not currently available,
and that can be used by policy makers and services provid-
ers to improve the services and programs that affect the
health of Indigenous people.
The second aim of the study – to work with an urban
Indigenous community to plan, implement and evaluate
interventions to reduce the incidence of diabetes among
those at high risk – was not able to be met due to inade-
quate numbers of participants with impaired fasting glu-
cose and impaired glucose tolerance. This was a function
of smaller than expected numbers of participants overall,
rather than a lower than expected prevalence of IFG and
IGT. In any case, the proposed intervention would have
had inadequate power to detect important differences. It
was therefore cancelled, with the relevant funds returned
to the National Health and Medical Research Council.
We had greater success in relation to our other aims,
although this is not always easy to demonstrate. The pro-
vision of individual results and advice and education
materials to participants as well as interaction with staff
members is likely to have increased awareness and under-
standing of diabetes among participants, although this
has not been formally assessed. We were clearly able to
provide employment and training opportunities for
Indigenous people, with 13 Indigenous staff members
over the course of the study, but facilitating community
engagement proved an ongoing challenge. By engaging
health service providers and referring participants with
specific health problems to relevant services, we facilitated
contact with, and use of, appropriate services for people
with diabetes and related conditions. It is difficult at this
point to determine the extent to which the study has con-
tributed to achieving our longer term aims of increasing
the capacity of Indigenous people to prevent diabetes and
increasing the capacity of Indigenous people with diabe-
tes and related disorders to manage their health in part-
nership with health service providers. Although there have
been reports of some participants having adopted health-
ier lifestyles, and of people with diabetes becoming more
involved in their health care following participation in the
study, it is not clear how widespread this has been, nor
whether any such changes have been maintained.
Despite the difficulties encountered in undertaking the
DRUID Study, and our inability to achieve all of our orig-
inal aims, the study was certainly not without its suc-
cesses. We recruited over 1,000 participants, of whom
approximately 94% provided a fasting blood sample. To
our knowledge, this is the largest study ever conducted on
the health of urban Indigenous Australians. As such it pro-
vides a valuable opportunity to establish a cohort study,
providing enough participants can be contacted and fol-
lowed over time. This will be assessed in the next phase of
the study, which involves annual follow-up of partici-
pants to collect information on their vital status, inci-
dence of selected major conditions and use of health
services. If most participants can be traced and contacted,
we will continue to follow the cohort over time, with a
view to repeat examinations in the future. This would
allow estimates of the incidence of diabetes and related
conditions to be made, as well as enable a better under-
standing of changes over time. It would also see the origi-
nal vision of the study achieved and would add
exponentially to its value.
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